Nasdaq

Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced results from time and motion studies ...
Seeking Alpha

Alcon Q2: Positive News From Unity VCS/CS And AR-15512

I reiterate a 'Strong Buy' rating for Alcon with a one-year price target of $115 per share, driven by new product pipelines and FDA clearances. Alcon's Unity VCS/CS systems received FDA clearance, set ...
Nasdaq

Alcon's Cataract Systems Unity VCS, Unity CS Get FDA 510(k) Clearance

(RTTNews) - Eye care company Alcon Inc. (ALC) announced Monday that UNITY Vitreoretinal Cataract System or VCS and UNITY Cataract System or CS have received U.S. Food and Drug Administration's 510(k) ...
Business Wire

Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance

GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY ® Vitreoretinal Cataract System ...
Business Wire

Alcon to Showcase Latest Innovations, Data at American Society of Retina Specialists 2020 Virtual Annual Meeting

Building on the advanced technology and enhanced visualization of the NGENUITY 3D Visualization System, Alcon will launch the NGENUITY 1.4 upgrade at ASRS. The upgrade includes a color optimization ...